Quantification of parasite load in clinical samples of leishmaniasis patients: Il-10 level correlates with parasite load in visceral leishmaniasis

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Verma, Sandeep ^a   Kumar, Rajesh ^a   Katara, Gajendra Kumar ^a   Singh, Laishram Chandreshwor ^a   Negi, Narender Singh ^a   Ramesh, V ^a   Salotra, Poonam ^a  

^a SAFDARJUNG HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIMONY GLUCONATE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; PROTOZOAL DNA;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW BIOPSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LEISHMANIA; MALE; PARASITE IDENTIFICATION; PARASITE TRANSMISSION; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS; BLOOD; BONE MARROW; GROWTH, DEVELOPMENT AND AGING; HOSPITALIZATION; ISOLATION AND PURIFICATION; LEISHMANIASIS; PARASITOLOGY; POLYMERASE CHAIN REACTION;

NASO HEXACANTHUS;

BIOLOGICAL MARKERS; BLOOD; BONE MARROW; DNA, PROTOZOAN; HUMANS; INTERLEUKIN-10; LEISHMANIA; LEISHMANIASIS; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX;

EID: 77956327706     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010107     Document Type: Article

References (49)

1. Desjeux P (2001) The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 95: 239-243.
2. Adhya S, Hassan MQ, Mukherjee S, Manna PP, Basu A, et al. (2002) Visceral leishmaniasis in India: promises and pitfalls of a PCR-based blood test. Trans R Soc Trop Med Hyg 96: 179-183.
3. Ramesh V, Singh R, Salotra P (2007) Post-kala-azar dermal leishmaniasis - an appraisal. Trop Med Int Health 12: 848-851.
4. Thakur CP, Kumar K (1992) Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes. Ann Trop Med Parasitol 86: 355-359.
5. Gradoni L, Scalone A, Gramiccia M (1993) HIV-Leishmania coinfections in Italy; serological data as an indication of the sequence of acquisition of the two infections. Trans R Soc Trop Med Hyg 87: 94-96.
6. Harris E, Kropp G, Belli A, Rodriguez B, Agabian N (1998) Single step multiplex PCR assay for characterization of New World Leishmania complexes. J Clin Microbiol 36: 1989-1995.
7. Salotra P, Sreenivas G, Pogue GP, Lee N, Nakhasi HL, et al. (2001) Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post kala-azar dermal leishmaniasis. J Clin Microbiol 39: 849-854.
8. Kumar R, Bumb RA, Ansari NA, Mehta RD, Salotra P (2007) Cutaneous leishmaniasis caused by Leishmania tropica in Bikaner, India: Parasite identification and characterization using molecular and immunological tools. Am J Trop Med Hyg 76: 896-901.
9. Jauregui LH, Higgins J, Zarlenga D, Dubey JP, Luney JK (2001) Development of a real-time PCR assay for detection of Toxoplasma gondii in pig and mouse tissues. J Clin Microbiol 39: 2065-2071.
10. Piron M, Fisa R, Casamitjana N, López-Chejade P, Puig L, et al. (2007) Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Trop 103: 195-200.
11. Perandin F, Manca N, Calderaro A, Piccolo G, Galati L, et al. (2004) Development of a real-time PCR assay for detection of Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale for routine clinical diagnosis. J Clin Microbiol 42: 1214-1219.
12. Bretagne S, Durand R, Olivi M, Garin JF, Sulahian A, et al. (2001) Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice. Clin Diagn Lab Immunol 8: 828-831.
13. Rolao S, Cortes S, Rodrigues OR, Campino L (2004) Quantification of Leishmania infantum parasites in tissue biopsies by real-time polymerase chain reaction-enzyme-linked immunosorbent assay. J Parasitol 90: 1150-1154.
14. Nicolas L, Prina E, Lang T, Milon G (2002) Real-time PCR for detection and quantitation of Leishmania in mouse tissues. J Clin Microbiol 40: 1666-1669.
15. Bossolasco S, Gaiera G, Olchini D, Gulletta M, Martello L, et al. (2003) Realtime PCR assay for clinical management of human immunodeficiency virusinfected patients with visceral leishmaniasis. J Clin Microbiol 4: 5080-5084.
16. Mary C, Faraut F, Lascombe L, Dumon H (2004) Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol 42: 5249-5255.
17. Selvapandiyan A, Stabler K, Ansari NA, Kerby S, Riemenschneider J, et al. (2005) A novel semiquantitative fluorescence-based multiplex polymerase chain reaction assay for rapid simultaneous detection of bacterial and parasitic pathogens from blood. J Mol Diagn 7: 268-275.
18. Wortman G, Hochberg L, Houng HH, Sweeney C, Zapor M, et al. (2007) Rapid identification of Leishmania complexes by a real-time PCR assay. Am J Trop Med Hyg 73: 999-1004.
19. Selvapandiyan A, Duncan R, Mendez J, Kumar R, Salotra P, et al. (2008) A Leishmania minicircle DNA footprint assay for sensitive detection and rapid speciation of clinical isolates. Transfusion 48: 1787-1798.
20. Alves CF, de Amorim IF, Moura EP, Ribeiro RR, Alves CF, et al. (2009) Expression of IFN-gamma, TNF-alpha, IL-10 and TGF-beta in lymph nodes associates with parasite load and clinical form of disease in dogs naturally infected with Leishmania (Leishmania) chagasi. Vet Immunol Immunopathol 128:349-358.
21. Scott P (1991) IFN-g modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 147:3149-3155.
22. Cenini P, Berhe N, Hailu A, McGinnes K, Frommel D (1993) Mononuclear cell populations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. J Infect Dis 168: 986-993.
23. Cillari E, Vitale G, Arcoleo F, Agostino PD, Mocciaro C, et al. (1995) In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis. Cytokine 7: 740-745.
24. van der Poll T, Zijlstra EE, Mevissen M (1995) Interleukin 6 during active visceral leishmaniasis and after treatment. Clin Immunol Immunopathol 77:111-114.
25. de Madeiros IM, Castelo A, Salomao R (1998) Presence of circulating levels of interferon-gamma, inteleukin-10 and tumor necrosis factor-alpha in patients with visceral leishmaniasis. Rev Inst Med Trop Sao Paulo 40: 31-34.
26. Hailu A, van der Poll T, Berhe N, Kager PA (2004) Elevated plasma levels of interferon (IFN)-c, IFN- c inducing cytokines, and IFN- c inducible CXC chemokines in visceral leishmaniasis. Am J Trop Med Hyg 71: 561-567.
27. Ghalib HW, Piuvezam MR, Skeiky YAW, Siddig M, Hashim FA, et al. (1993) Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 92: 324-329.
28. Karp CL, El-Safi SH, Wynn TA, Satti MMH, Kordofani AM, et al. (1993) In vivo cytokine profiles in patients with kala azar. Marked elevation of both interleukin-10 and interferon-gamma. J Clin Invest 91: 1644-1648.
29. Salotra P, Sreenivas G, Beena KR, Mukherjee A, Ramesh V (2003) Parasite detection in patients with post kala-azar dermal leishmaniasis in India: a comparison between molecular and immunological methods. J Clin Pathol 56: 840-843.
30. Zijlstra EE, Khalil EA, Kager PA, El-Hassan AM (2000) Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis. Br J Dermatol 143: 136-143.
31. Kumar R, Bumb RA, Salotra P (2009) Correlation of parasitic load with interleukin-4 response in patients with cutaneous leishmaniasis due to Leishmania tropica. FEMS Immunol Med Microbiol 57: 239-246.
32. Miralles GD, Stoeckle MY, McDermott DF, Finkelman FD, Murray HW (1994) Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect Immun 62: 1058-1063.
33. Manna L, Reale S, Picillo E, Vitale F, Gravino AE (2008) Interferon-gamma (INF-c), IL4 expression levels and Leishmania DNA load as prognostic markers for monitoring response to treatment of leishmaniotic dogs with miltefosine and allopurinol. Cytokine 44: 228-292.
34. Manna L, Reale S, Vitale F, Gravino AE (2009) Evidence for a relationship between Leishmania load and clinical manifestations. Res Vet Sc 87: 76-78.
35. Mitra RS, Judge TA, Nestle FO, Turka LA, Nickoloff BJ (1995) Psoriatic skinderived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. J Immunol 154:2668-2677.
36. Taga K, Tosato G (1992) IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 148: 1143-1148.
37. Gazzinelli RT, Oswald IP, James SL, Sher A (1992) IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages.J Immunol 148: 1792-1796.
38. Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, et al. (1995) Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 155: 722-729.
39. Fernandes DM, Baldwin CL (1995) Interleukin-10 downregulates protective immunity to Brucella abortus. Infect Immun 63: 1130-1133.
40. Romani L, Puccetti P, Mencacci A, Cenci E, Spaccapelo R, et al. (1994) Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J Immunol 152:3514-3521.
41. Reed SG, Brownell CE, Russo DM, Silva JS, Grabstein KH, et al. (1994) IL-10 mediates susceptibility to Trypanosoma cruzi infection. J Immunol 153: 3135-3140.
42. Denis M, Ghadirian E (1993) IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. J Immunol 151: 5425-5430.
43. Belkaid Y, Hoffmann KF, Mendez S, Kamhawi S, Udey MC, et al. (2001) The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 194: 1497-506.
44. Ansari NA, Saluja S, Salotra P (2006) Elevated levels of interferon-c, interleukin- and interleukin-6 during active disease in Indian kala azar. Clin Immunol 119: 339-345.
45. Ansari NA, Ramesh V, Salotra P (2006) Interferon (IFN)-c, tumor necrosis factor- a, interleukin-6, and IFN-c receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis. J Infect Dis194: 958-965.
46. Peruhype-Magalha V, Martins-Filho O A, Prata A, Silva Lde A, Rabello A, et al. (2006) Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection. Clin Exp Immunol 146:124-132.
47. Caldas A, Favali C, Aquino D, Vinhas V, van Weyenbergh J, et al. (2005) Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infect Dis 5: 113.
48. Sundar S, More DK, Singh MK, Singh VP, Sharma S, et al. (2000) Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 31: 1104-1107.
49. Sundar S, Gupta LB, Rastogi V, Agrawal G, Murray HW (2000) Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis. Trans R Soc Trop Med Hyg 94: 200-204.